Research Analysts Offer Predictions for MLTX FY2025 Earnings
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Stock analysts at Leerink Partnrs increased their FY2025 earnings estimates for MoonLake Immunotherapeutics in a research report issued to clients and investors on Tuesday, May 13th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings per share of ($3.02) for the year, up from […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Stock analysts at Leerink Partnrs increased their FY2025 earnings estimates for MoonLake Immunotherapeutics in a research report issued to clients and investors on Tuesday, May 13th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings per share of ($3.02) for the year, up from […]
